Recent News

521 News Items found
Klavdija Bastl
Learn about how first-year student get oriented to the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).
A collage of photos showing a zebrafish with GFP-labeled melanocytes, magnified GFP-labeled melanocytes, and hPSC-derived melanocytes growing in a dish.
Experiments with zebrafish and human pluripotent stem cells reveal the necessary ingredients, besides genetic mutations, that fuel the development of melanoma.
Computational biologist Quaid Morris
In the Lab
A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
Scientist Gabriela Chiosis in her lab
In the Lab
Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Memorial Sloan Kettering surgeon Prasad Adusumilli
Q&A
A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
Announcement
Meet the 11 new faculty members that have joined the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.
MSK radiologist Andreas Wibmer
People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.
Memorial Sloan Kettering immunologist Frederic Geissmann
Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.
Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes.